Function: Relieves the suppression of cancer cells on the immune system, enhancing the body’s natural cancer-fighting ability.
Indications: Melanoma, non-small cell lung cancer, kidney cancer, cervical cancer, etc.
Ideal for: PD-L1 positive patients or those who have failed standard treatments.
Clinical Use: Monotherapy or combination therapy.
Function: Modifies the patient's T-cells to precisely identify and destroy tumors.
Indications: Acute lymphoblastic leukemia, B-cell lymphoma, etc.
Ideal for: Refractory hematological cancers or recurrent cases.
Clinical Use: Cell-based immunotherapy, bridging therapy.
Function: Expands immune cells in vitro and then re-infuses them to enhance immune cell killing power.
Indications: All solid tumors and some hematologic cancers.
Ideal for: Patients with low immunity or those requiring postoperative consolidation therapy.
Clinical Use: Supportive immune therapy, anti-relapse strategy.
